Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers

被引：0
|
作者：
Schlosser, Shir
Molho, Rinat Bernstein
Karminsky, Natalia
Barsuk, Daphna
Goldberg, Yael
Friedman, Eitan
Yerushalmi, Rinat
Drumea, Keren
Kedar, Inbal
Jiveliouk, Irina
Ben David, Merav Akiva
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-09-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-16
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation
    Schmidt, Marjanka K.
    Tollenaar, Rob A. E. M.
    de Kemp, Sanne R.
    Broeks, Annegien
    Cornelisse, Cees J.
    Smit, Vincent T. H. B. M.
    Peterse, Johannes L.
    van Leeuwen, Flora E.
    Van't Veer, Laura J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 64 - 69
  • [42] The risk of gastric cancer in carriers of CHEK2 mutations
    Teodorczyk, Urszula
    Cybulski, Cezary
    Wokolorczyk, Dominika
    Jakubowska, Anna
    Starzynska, Teresa
    Lawniczak, Malgorzata
    Domagala, Pawel
    Ferenc, Katarzyna
    Marlicz, Krzysztof
    Banaszkiewicz, Zbigniew
    Wisniowski, Rafal
    Narod, Steven A.
    Lubinski, Jan
    FAMILIAL CANCER, 2013, 12 (03) : 473 - 478
  • [43] The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic
    Kleibl, Z
    Novotny, J
    Bezdickova, D
    Malik, R
    Kleiblova, P
    Foretova, L
    Petruzelka, L
    Ilencikova, D
    Cinek, P
    Pohlreich, P
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (02) : 165 - 167
  • [44] The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic
    Zdenek Kleibl
    Jan Novotny
    Drahomira Bezdickova
    Radek Malik
    Petra Kleiblova
    Lenka Foretova
    Lubos Petruzelka
    Denisa Ilencikova
    Petr Cinek
    Petr Pohlreich
    Breast Cancer Research and Treatment, 2005, 90 : 165 - 167
  • [45] Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
    Xie, Changqing
    Tanakchi, Sally
    Raygada, Margarita
    Davis, Jeremy L.
    Del Rivero, Jaydira
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (01): : 284 - 290
  • [46] Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer
    Laitman, Yael
    Kaufman, Bella
    Lahad, Ephrat Levy
    Papa, Moshe Z.
    Friedman, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 791 - 796
  • [47] The risk of gastric cancer in carriers of CHEK2 mutations
    Urszula Teodorczyk
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Teresa Starzyńska
    Małgorzata Ławniczak
    Paweł Domagała
    Katarzyna Ferenc
    Krzysztof Marlicz
    Zbigniew Banaszkiewicz
    Rafał Wiśniowski
    Steven A. Narod
    Jan Lubiński
    Familial Cancer, 2013, 12 : 473 - 478
  • [48] Effect of a CHEK2 mutation on the advancing disease progression of breast cancer patients
    Meyer, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 57 - 57
  • [49] Alternative splicing and mutation status of CHEK2 in stage III breast cancer
    Staalesen, V
    Falck, J
    Geisler, S
    Bartkova, J
    Borresen-Dale, AL
    Lukas, J
    Lillehaug, JR
    Bartek, J
    Lonning, PE
    ONCOGENE, 2004, 23 (52) : 8535 - 8544
  • [50] Germline mutation of CHEK2 in neurofibromatosis 1 and 2 Two case reports
    Li, Qiang
    Zhao, Feilong
    Ju, Yan
    MEDICINE, 2018, 97 (23)
12345